These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 31350321

  • 21. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
    Stabile A, Dell'Oglio P, De Cobelli F, Esposito A, Gandaglia G, Fossati N, Brembilla G, Cristel G, Cardone G, Deho' F, Losa A, Suardi N, Gaboardi F, Del Maschio A, Montorsi F, Briganti A.
    Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
    [Abstract] [Full Text] [Related]

  • 22. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
    Gómez Rivas J, Giganti F, Álvarez-Maestro M, Freire MJ, Kasivisvanathan V, Martinez-Piñeiro L, Emberton M.
    Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
    [Abstract] [Full Text] [Related]

  • 23. [68Ga-PSMA-11 PET/mpMRI for local detection of primary prostate cancer in men with a negative prior biopsy].
    Maurer T, Gesterkamp H, Nguyen N, Westenfelder K, Gschwend JE, Budäus L, Rauscher I, Vag T, Weber W, Eiber M.
    Aktuelle Urol; 2021 Apr; 52(2):143-148. PubMed ID: 32854128
    [Abstract] [Full Text] [Related]

  • 24. Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis.
    Gulati R, Jiao B, Al-Faouri R, Sharma V, Kaul S, Fleishman A, Wymer K, Boorjian SA, Olumi AF, Etzioni R, Gershman B.
    Ann Intern Med; 2024 Jul; 177(7):871-881. PubMed ID: 38830219
    [Abstract] [Full Text] [Related]

  • 25. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
    Luzzago S, Petralia G, Musi G, Catellani M, Alessi S, Di Trapani E, Mistretta FA, Serino A, Conti A, Pricolo P, Nazzani S, Mirone V, Matei DV, Montanari E, de Cobelli O.
    Clin Genitourin Cancer; 2019 Apr; 17(2):88-96. PubMed ID: 30527286
    [Abstract] [Full Text] [Related]

  • 26. Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging.
    Al-Bayati M, Grueneisen J, Lütje S, Sawicki LM, Suntharalingam S, Tschirdewahn S, Forsting M, Rübben H, Herrmann K, Umutlu L, Wetter A.
    Urol Int; 2018 Apr; 100(2):164-171. PubMed ID: 29393268
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP, Sala E, Shaida N, Koo B, Warren AY, Carmisciano L, Saeb-Parsy K, Gnanapragasam VJ, Kastner C, Barrett T.
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [Abstract] [Full Text] [Related]

  • 28. Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study.
    Bodar YJL, Zwezerijnen BGJC, van der Voorn PJ, Jansen BHE, Smit RS, Kol SQ, Meijer D, de Bie K, Yaqub M, Windhorst BAD, Hendrikse HNH, Vis AN, Oprea-Lager DE.
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1731-1742. PubMed ID: 34725727
    [Abstract] [Full Text] [Related]

  • 29. Using decision curve analysis to benchmark performance of a magnetic resonance imaging-based deep learning model for prostate cancer risk assessment.
    Deniffel D, Abraham N, Namdar K, Dong X, Salinas E, Milot L, Khalvati F, Haider MA.
    Eur Radiol; 2020 Dec; 30(12):6867-6876. PubMed ID: 32591889
    [Abstract] [Full Text] [Related]

  • 30. Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Kang SK, Mali RD, Prabhu V, Ferket BS, Loeb S.
    Radiology; 2021 Sep; 300(3):594-604. PubMed ID: 34254851
    [No Abstract] [Full Text] [Related]

  • 31. PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.
    Tran V, Hong A, Sutherland T, Taubman K, Lee SF, Lenaghan D, Sethi K, Corcoran NM, Lawrentschuk N, Woo H, Tarlinton L, Bolton D, Spelman T, Thomas L, Booth R, Hegarty J, Perry E, Wong LM.
    BMJ Open; 2022 Sep 19; 12(9):e061815. PubMed ID: 36123093
    [Abstract] [Full Text] [Related]

  • 32. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.
    Panebianco V, Valerio MC, Giuliani A, Pecoraro M, Ceravolo I, Barchetti G, Catalano C, Padhani AR.
    Eur Urol Oncol; 2018 Aug 19; 1(3):208-214. PubMed ID: 31102623
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
    Lee MS, Cho JY, Kim SY, Cheon GJ, Moon MH, Oh S, Lee J, Lee S, Woo S, Kim SH.
    J Magn Reson Imaging; 2017 Feb 19; 45(2):597-609. PubMed ID: 27586519
    [Abstract] [Full Text] [Related]

  • 34. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP, Schwab C, Wolf MB, Freitag MT, Alt CD, Kesch C, Popeneciu IV, Huettenbrink C, Gasch C, Klein T, Bonekamp D, Duensing S, Roth W, Schueler S, Stock C, Schlemmer HP, Roethke M, Hohenfellner M, Hadaschik BA.
    Eur Urol; 2016 Nov 19; 70(5):846-853. PubMed ID: 26810346
    [Abstract] [Full Text] [Related]

  • 35. Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy.
    Mannaerts CK, Engelbrecht MRW, Postema AW, van Kollenburg RAA, Hoeks CMA, Savci-Heijink CD, Van Sloun RJG, Wildeboer RR, De Reijke TM, Mischi M, Wijkstra H.
    BJU Int; 2020 Oct 19; 126(4):481-493. PubMed ID: 32315112
    [Abstract] [Full Text] [Related]

  • 36. Comparison of different thresholds of PSA density for risk stratification of PI-RADSv2.1 categories on prostate MRI.
    Girometti R, Giannarini G, Panebianco V, Maresca S, Cereser L, De Martino M, Pizzolitto S, Pecoraro M, Ficarra V, Zuiani C, Valotto C.
    Br J Radiol; 2022 Mar 01; 95(1131):20210886. PubMed ID: 34762506
    [Abstract] [Full Text] [Related]

  • 37. Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.
    Gaur S, Harmon S, Mehralivand S, Bednarova S, Calio BP, Sugano D, Sidana A, Merino MJ, Pinto PA, Wood BJ, Shih JH, Choyke PL, Turkbey B.
    J Magn Reson Imaging; 2018 Nov 01; 48(5):1326-1335. PubMed ID: 29603833
    [Abstract] [Full Text] [Related]

  • 38. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR, Viana PC, Mattedi RL, Guglielmetti GB, Cordeiro MD, Coelho RF, Nahas WC, Srougi M.
    BJU Int; 2017 Apr 01; 119(4):535-542. PubMed ID: 27500389
    [Abstract] [Full Text] [Related]

  • 39. Recurrent prostate cancer after radical prostatectomy: restaging performance of 18F-choline hybrid PET/MRI.
    Achard V, Lamanna G, Denis A, De Perrot T, Mainta IC, Ratib O, Iselin C, Miralbell R, Garibotto V, Zilli T.
    Med Oncol; 2019 Jun 12; 36(8):67. PubMed ID: 31190232
    [Abstract] [Full Text] [Related]

  • 40. MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
    Sheridan AD, Nath SK, Aneja S, Syed JS, Pahade J, Mathur M, Sprenkle P, Weinreb JC, Spektor M.
    AJR Am J Roentgenol; 2018 May 12; 210(5):W218-W225. PubMed ID: 29489409
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.